Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
marisa.cabrita@nds.ox.ac.uk

Research groups

The RESPOND Programme

Marisa Cabrita

Clinical Trial Manager for RESPOND

Recent publications

Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states.
Journal article

Layton TB. et al, (2020), Nat Commun, 11
Cellular census of human fibrosis defines functionally distinct stromal cell types and states.
Journal article

Layton TB. et al, (2020), Nat Commun, 11
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states.
Journal article

Layton TB. et al, (2020), Biol Open, 9
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis.
Journal article

Izadi D. et al, (2019), Sci Adv, 5
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
Journal article

Nanchahal J. et al, (2018), EBioMedicine, 33, 282 - 288

More publications